Form 8-K - Current report:
SEC Accession No. 0001104659-21-136368
Filing Date
2021-11-09
Accepted
2021-11-09 17:14:58
Documents
27
Period of Report
2021-11-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132351d1_8k.htm   iXBRL 8-K 26193
2 EXHIBIT 99.1 tm2132351d1_ex99-1.htm EX-99.1 13149
3 EXHIBIT 99.2 tm2132351d1_ex99-2.htm EX-99.2 10615
7 GRAPHIC tm2132351d1_ex99-1img001.jpg GRAPHIC 94643
8 GRAPHIC tm2132351d1_ex99-1img002.jpg GRAPHIC 90727
9 GRAPHIC tm2132351d1_ex99-1img003.jpg GRAPHIC 41890
10 GRAPHIC tm2132351d1_ex99-1img004.jpg GRAPHIC 70808
11 GRAPHIC tm2132351d1_ex99-1img005.jpg GRAPHIC 65994
12 GRAPHIC tm2132351d1_ex99-1img006.jpg GRAPHIC 76766
13 GRAPHIC tm2132351d1_ex99-1img007.jpg GRAPHIC 70251
14 GRAPHIC tm2132351d1_ex99-1img008.jpg GRAPHIC 70392
15 GRAPHIC tm2132351d1_ex99-1img009.jpg GRAPHIC 67563
16 GRAPHIC tm2132351d1_ex99-1img010.jpg GRAPHIC 88856
17 GRAPHIC tm2132351d1_ex99-1img011.jpg GRAPHIC 67293
18 GRAPHIC tm2132351d1_ex99-1img012.jpg GRAPHIC 66949
19 GRAPHIC tm2132351d1_ex99-2img003.jpg GRAPHIC 4063
  Complete submission text file 0001104659-21-136368.txt   1439955

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20211108.xsd EX-101.SCH 3195
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20211108_lab.xml EX-101.LAB 34594
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20211108_pre.xml EX-101.PRE 22717
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2132351d1_8k_htm.xml XML 3618
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 211393254
SIC: 2836 Biological Products, (No Diagnostic Substances)